Hechmati, Guy <br/><br/>
Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  Jan 2015 
 - 21-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-014-2309-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Bone and Bones--pathology<br/>Choice Behavior<br/>Denosumab<br/>Diphosphonates--therapeutic use<br/>Female<br/>France<br/>Germany<br/>Humans<br/>Imidazoles--therapeutic use<br/>Kidney Diseases--epidemiology<br/>Male<br/>Middle Aged<br/>Osteonecrosis--epidemiology<br/>Pain--drug therapy<br/>Patient Participation<br/>Patient Preference--psychology<br/>RANK Ligand--antagonists & inhibitors<br/>Treatment Outcome<br/>United Kingdom<br/>Zoledronic Acid